Saatja: WHO EURO HRH Framework for Action <
[email protected]>
Saadetud: 26.11.2021 15:03
Adressaat: Kaija Kasekamp <
[email protected]>; SM Info <
[email protected]>
Koopia: TILLE, Florian <
[email protected]>; Essential Health Services
Monitoring <
[email protected]>; KÖHLER, Kristina <
[email protected]>
Teema: FW: EST - National pulse survey on the continuity of essential
health services during the COVID-19 pandemic
Dear Ms Kasekamp,
Regarding the third round of the National Pulse Survey on the Continuity
of Essential Health Services during the COVID-19 Pandemic, I would like
to inform you that the deadline for completion has been extended by
another two weeks, until 14 December 2021.
I very much hope that this will make it more feasible to respond to the
survey in the midst of many other competing priorities. I encourage the
submission of responses particularly for the core Continuity of EHS
module (section 1 of the survey).
Once more, I would like to thank you for assisting in disseminating the
survey and facilitating its completion in your country.
Would you need any assistance or clarification, please do not hesitate to
contact us addressing your queries to Florian Tille () and .
Thank you very much.
Best regards,
Natasha
From: WHO EURO HRH Framework for Action Sent: Wednesday, November 17,
2021 1:20 PMTo:
[email protected];
[email protected]: KÖHLER, Kristina
<
[email protected]>Subject: FW: EST - National pulse survey on the
continuity of essential health services during the COVID-19 pandemic
Dear Ms Kasekamp,
This is a gentle reminder regarding the third round of the national pulse
survey on the continuity of essential health services during the COVID-19
pandemic.
We would be grateful if you can assist in disseminating the survey to the
Ministry of Health and facilitate its completion. We would also like to
inform you that the deadline for completion has been extended by one
week, to 30 November 2021.
We understand the current constraints on your time and pressure on your
office and I would like to stress out how grateful I am for your
continuous support and your collaboration in assisting your country in
completing this survey.
Would you need any assistance or clarification, please do not hesitate to
contact us addressing your queries to Florian Tille () and .
Thank you very much.
Best regards,
Natasha
From: WHO EURO HRH Framework for Action Sent: Monday, November 8, 2021
10:58 AMTo: Cc: ; KÖHLER, Kristina <>; Essential Health Services
Monitoring <>; EURO Strategic Relations with Countries <>;
EGGERS, Rudi <>; O'NEILL, Kathryn <>; ZAPATA, Tomas <>;
TILLE, Florian <>; DELL AMURA, Lucia <>Subject: EST -
National pulse survey on the continuity of essential health services
during the COVID-19 pandemic
Dear Ms Kasekamp,
Please find attached a letter (with enclosure) from the Director,
Division of Country Health Policies and Systems, related to the third
round of the national pulse survey on the continuity of essential health
services during the COVID-19 pandemic.
Yours sincerely,
Lisa Copple, Programme AssistantDivision of Country Health Policies and
Systems
National pulse survey on continuity of essential health services during the
COVID-19 pandemic
Purpose
The National pulse survey on continuity of essential health services during the COVID-19 pandemic aims to
rapidly assess the impact of the COVID-19 pandemic on health systems and essential health services throughout
the course of the pandemic. The survey provides insight from country key informants into the current country
situation, the extent of disruptions, and how countries are responding to mitigate challenges and recover
services against a rapidly changing context.
Data use
Once the survey is completed, countries are encouraged to use the results – combined with other data – to
inform roundtable discussions and policy dialogues to identify critical bottlenecks and guide priority actions.
Key informants and content areas
The pulse survey consists of questions related to current national policies, plans and structures, disruptions to
health services, reasons for disruptions, mitigation strategies, recovery approaches, information tracking, and
priority needs. Different survey sections target different key informants in the country. The online survey has
been designed so that each section can be answered simultaneously by respective country focal points to
facilitate rapid completion, reduce burden, and ensure that each content area is assessed by its respective
technical focal point. Survey sections and suggested key informants are in the table below. Please note this
survey round does not include a section on noncommunicable diseases because a separate WHO survey with
comparable data has recently been conducted.
# Outline of survey modules Suggested key informant(s)
1. Continuity of essential health services module
- Policies, planning and investment Health system, service delivery, or essential health
- Service disruptions across service delivery services incident management support team focal
platforms point(s)
- Mitigation strategies and recovery measures
- Information tracking
- Health system bottlenecks and priority needs
to support delivery of:
o essential health services
o essential COVID-19 tools
In-depth modules on disruptions to tracer service areas
2. Sexual, reproductive, maternal, newborn, child and Sexual, reproductive, maternal, newborn, child and
adolescent health adolescent health focal point(s)
3. Nutrition Nutrition focal point(s)
4. Immunization Immunization focal point(s)
5. Human immunodeficiency virus and hepatitis Human immunodeficiency virus and hepatitis focal
point(s)
6. Tuberculosis Tuberculosis focal point(s)
7. Malaria Malaria focal point(s)
8. Neglected tropical diseases Neglected tropical diseases focal point(s)
9. Mental, neurological and substance use disorders Mental health, neurology and substance abuse focal
point(s)
10. Care for older people Care for older people focal point(s)
1
Reporting period
The questions refer to the 6-month time period preceding the month of survey completion. In the case of
survey completion in November, this refers to: May-October 2021.
Suggested modality for completion
It is recommended that a survey focal point (from WHO CO and/or within the Ministry of Health as appropriate
to country context) be designated to lead the survey coordination process, including:
1. Identifying national focal points/key informants to complete each survey section (for some in-depth
modules, this may involve representatives from relevant professional associations if there are no
designated ministerial level focal points);
2. Disseminating the survey link to relevant national focal points/key informants;
3. Tracking and following up completion of survey sections; and
4. As feasible, organizing follow up activities and dialogues to support data use.
Ideally, survey key informants will come together in a collaborative discussion to review and align responses
across survey sections prior to submission. If this is not possible, each section can be completed independently
by its respective key informant.
How to submit responses online
Please click on the survey section links to review the WHO data sharing agreement (annex 1) and access the
survey. Key informants may access the survey sections as many times as needed, saving responses along the
way. Please note that multiple users cannot access the same section at the same time. A single key informant
should be designated to complete each survey section to reduce the risk of overwriting other’s responses should
multiple key informants enter a survey section. Once each section is submitted, the answers may be printed for
record.
Please note that all personal and identifying details will be kept confidential and not included in reporting. These
details will only be used to follow up in the case of any clarifications.
Large decentralized countries may consider completion of the pulse survey at the subnational level to then be
aggregated at the national level. If this may be of interest, please contact
[email protected] for survey
support.
Survey responses will be accepted until 23 November 2021.
2
Continuity of essential health services
To be completed by: Health system, service delivery, or essential health services incident management
support team focal point(s)
This section will assess cross-cutting health system areas, including: national policies and plans; disruptions to
service delivery platforms and cross-cutting services for primary, inpatient, emergency, rehabilitative, and
palliative care; reasons for service disruptions; mitigation strategies and recovery approaches; and information
tracking. It also includes a sub-section on health system bottlenecks related to COVID-19 case management.
Respondent information
Who is the focal point(s) who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
Policies and planning
1. Has your country developed 1. Yes, developed
and/or revised a policy or plan 2. Yes, developed and revised in last 6 months
for continuity of essential health 3. No, does not exist
services during the COVID-19 4. Do not know
pandemic?
If yes, please upload or link the most recent policy or plans (if not already
uploaded during previous survey round).
2. Has your country developed or 1. Yes
revised a health system recovery 2. No
plan to strengthen health service 3. Not yet, but planning to develop
resilience and preparedness for 4. Do not know
future public health
emergencies? If yes, please upload or link the plan.
3. During the previous 6 months, Primary care services (including family medicine) [ ] Functioning as normal
how have government policies [ ] Limited
and directives affected Outpatient specialist services [ ] Suspended
functioning of the following [ ] Do not know
service delivery platforms? Inpatient services
Please respond for each service Emergency unit services
delivery platform.
Prehospital emergency care services (e.g.
ambulance transport)
Community-based care (e.g. outreach
campaigns, home-based care, care in long-term
facilities)
3
Mobile clinics
4. During the previous 6 months, Health protection (e.g. management of [ ] Functioning as normal
how have government policies environmental, food, toxicological and [ ] Limited
and directives affected the occupational safety) [ ] Suspended
following essential public health [ ] Do not know
functions and activities? Health promotion population-based activities
Please respond for each function Disease prevention population-based activities
or activity.
Surveillance and response
Emergency preparedness and response
Communications and social mobilization
activities for health
Public health research
5. At what level(s) does decision- 1. Central Ministry of Health
making and/or development of 2. Decentralized Health Authorities
policies and strategies for 3. Individual facilities
adapting and restoring essential 4. Do not know
health services during COVID-19
take place?
Please check all that apply.
6. During 2021, has the 1. Maintaining essential health services during [ ] Yes
government allocated additional the COVID-19 pandemic (e.g. service [ ] No
funding for the following areas? delivery modifications, catch up strategies) [ ] Do not know
2. Longer-term health system recovery and/or
Please respond for each area. health service resilience and preparedness
If yes to answer 2, in which of the following sub-
areas have investments been made?
Please check all that apply:
a. New facility infrastructure
b. Digital health technologies and
infrastructure
c. Health workforce capacity strengthening
d. Access to medicines, supplies and other
health products
e. Technologies and methods to support
infodemic management
f. Do not know
Service disruptions
7. 7.a Please indicate the level of disruption due to 7.b How does this level of 7.c What was the
COVID-19 during the previous 6 months (i.e. disruption compare to the primary reason for this
level of disruption during disruption?
4
percentage of users not served as usual compared to the first quarter of 2021
before the pandemic) for the following service areas. (January-March 2021)?
Please respond for each service area.
Routine scheduled primary care [ ] More than 50% [ ] Still disrupted, worse [ ] Intentional service
clinic services [ ] 26-50% than Jan-March 2021 delivery modifications
[ ] 5-25% [ ] Still disrupted, better [ ] Decreased care-
Unscheduled primary care clinic [ ] Less than 5% than Jan-March 2021 seeking
services (including 0%) [ ] Still disrupted, no [ ] Unintended
[ ] Do not know change from Jan-March disruptions due to lack of
Appointments with specialists [ ] Not applicable 2021 health care resources
(outpatient) [ ] Back to pre-pandemic [ ] Do not know
levels
Prescription renewals for chronic [ ] Do not know
medications
Cancer screening
Cancer treatment
Prehospital emergency care
services (e.g. ambulance
transport)
24-hour emergency unit services
Outreach services (mobile clinics,
campaigns, etc.)
Health post and home visits by
community health workers
Hospital inpatient services
Elective surgeries and
procedures
Emergency surgeries
Rehabilitative services
Palliative services
8. During the previous 6 months, 1. Yes
have there been disruptions to 2. No
the in-country supply chain 3. Do not know
system?
9. During the previous 6 months, Elective surgeries and procedures 1. Decreased
what has been the trend in 2. Increased
5
backlogs for the following service Appointments with specialists (outpatient) 3. Not applicable
areas? 4. Do not know
Screening, diagnosis and treatment of cancers
Please respond for each service
area. Screening, diagnosis and treatment of
noncommunicable diseases
Rehabilitation services
Mitigation strategies and recovery measures
10. During the previous 6 months, Service delivery modifications
what have been the most 1. Expansion of facility hours
successful approaches to 2. Provision of home-based care where appropriate
overcome service disruptions? 3. Telemedicine deployment to replace in-person consults
4. Use of self-care interventions where appropriate
Please check all that apply. 5. Catch-up campaigns for missed appointments
6. Integration of several services into single visit
Please only select the strategies 7. Redirection of patients to alternate care sites /reorientation of referral
or measures that have been pathways
major contributors to Health worker capacities and training
overcoming disruptions. 8. Redistribution of health worker tasks and optimization of roles
9. Rapid training mechanisms and job aids for key capacities and newly
distributed tasks and roles (e.g. essential IPC measures, use of digital
tools, screening, triage, etc.)
10. Recruitment of additional staff
11. Provision of mental health care and psychosocial support to health
workers
12. Establishment of pathways for accelerated training and early
certification of medical, nursing and other key staff (with appropriate
controls in place)
13. Paid sick leave, overtime pay, and/or hazard pay
Access to medicines and health products
14. Novel approaches to renewing prescriptions and dispensing medications
15. Adaption of supply chain logistics and management processes
16. Procurement of surge commodities (e.g. personal protective equipment
(PPE), oxygen)
Community engagement and risk communication strategies
17. Community communications (e.g. informing on changes to service
delivery, addressing misinformation and community fears of infection,
targeted outreach where utilization has declined, hotlines)
18. Use of proactive governmental strategies to reach vulnerable groups
19. Use of existing networks or organizations (e.g. NGOs) to reach
vulnerable groups
Health financing strategies
20. Removal of user fees or provision of subsidies for fees at point of use
21. Provision of cash transfers for vulnerable populations to access care
(e.g. refugees and migrants)
6
22. Agreements with private health facilities to deliver essential health
services supported through public funds
Other
23. Others (please specify):
24. Do not know
25. Not applicable
Information tracking
11.a Is your country regularly 1. Yes
monitoring the continuity of 2. No
essential health services during 3. Do not know
the COVID-19 pandemic?
11.b If yes to 11.a, does this include 1. Yes
regular monitoring of mitigation 2. No
or recovery strategies to 3. Do not know
overcome service disruptions?
11.c If yes to 11.a, does this include 1. Yes
regular monitoring of the long- 2. No
term effects of essential health 3. Do not know
service disruptions (e.g. excess
morbidity and mortality)?
12. Has your country produced one 1. Yes
or more qualitative or 2. No
quantitative analysis of health 3. Do not know
inequities during the COVID-19
pandemic (e.g. report, paper,
research)?
13. Is your country collecting or 1. Yes
collating data on comorbidities in 2. No
COVID-19 patients? 3. Do not know
14. Is your country collecting or 1. Yes
collating patient-level data on 2. No
post-COVID-19 condition and its 3. Do not know
sequelae?
15. Does your country currently have 1. Yes, within Ministry of Health or equivalent
a team dedicated to tracking and 2. Yes, within government but in another ministry
addressing the infodemic and 3. Not yet, but planning on setting up a unit
health misinformation? 4. No unit, but we have staff completing these tasks
(e.g. a taskforce or unit for: 5. No
analyzing and monitoring 6. Do not know
misinformation online and offline,
and how it affects acceptance of
public health measures and health
seeking behaviors; analyzing and
proposing evidence-based
interventions to counter
misinformation at national,
subnational, community and
individual levels)
7
Priority needs to support continuity of essential health services
16. What are your most urgent Please use the text box to give your suggestions
priority needs and technical
assistance requirements from
WHO for continuity of essential
health services during the
COVID-19 pandemic?
Health system bottlenecks and priority needs to support delivery of COVID-19 essential tools
17.a What are the three main 1. Lack of funding (e.g. to procure or deliver laboratory supplies and
bottlenecks for potential scale up equipment)
of COVID-19 diagnostic and 2. Health workforce challenges (e.g. insufficient quantities, distribution or
testing capacities in your competencies to administer tests)
country? 3. Shortages in laboratory supplies and equipment at central or facility
levels
4. Lack of distribution capacity (e.g. supply delays at central level)
5. Lack of clear strategy, guidance or protocols for diagnosis and testing
6. Lack of data/information to monitor progress and needs
7. Demand-side challenges (e.g. community acceptance for testing,
affordability)
8. Other (please specify)
9. None/scale up not needed (skip next question)
17.b What are the three main 1. Financial planning support
technical assistance or support 2. Health worker recruitment, retention and training
interventions needed to address 3. Operational guidance and protocols for supply chain management
these bottlenecks? 4. Surge procurement of COVID-19 laboratory supplies and equipment
5. Guidance on developing national policies, strategies, or plans for scale
up of diagnosis and testing
6. Rapid tools or guidance to assess and monitor gaps and health system
absorption capacities
7. Risk communication and community engagement strategies
8. Other (please specify)
18.a What are the three main 1. Lack of funding (e.g. to procure or deliver medicines, medical supplies,
bottlenecks for potential scale up oxygen, and ventilators)
of COVID-19 case management 2. Health workforce challenges (e.g. insufficient quantities, distribution, or
capacities in your country? competencies to treat patients)
3. Shortages in COVID-19 therapeutics and equipment (e.g. lack of
medicines, medical supplies, oxygen, ventilators and beds at central or
facility levels)
4. Lack of distribution capacity (e.g. supply delays at central level in
medicines, medical supplies, oxygen, and ventilators)
5. Lack of clear strategy, guidance or protocols for COVID-19 case
management suited to context
6. Lack of data/information to monitor progress and needs
7. Demand-side challenges (e.g. community acceptance for treatment,
affordability)
8. Other (please specify)
9. None/scale up not needed (skip next question)
8
18.b What are the three main 1. Financial planning support
technical assistance or support 2. Health worker recruitment, retention and training
interventions needed to address 3. Operational guidance and protocols for supply chain management
these bottlenecks? 4. Surge procurement of COVID-19 related therapeutics and equipment
(e.g. oxygen, ventilators)
5. Guidance on developing national policies, strategies, or plans for scale
up of case management capacities
6. Rapid tools or guidance to assess and monitor gaps and health system
absorption capacities
7. Risk communication and community engagement strategies
8. Other (please specify)
19.a What are the three main 1. Lack of funding (e.g. to procure or deliver PPE)
bottlenecks for potential scale up 2. Health workforce challenges (e.g. lack of knowledge on appropriate use
of PPE distribution and use in of PPE)
your country? 3. Shortages in PPE at central or facility level (including size and quality
issues of available PPE)
4. Lack of distribution capacity (e.g. supply delays at central level)
5. Lack of clear strategy, guidance or protocols on appropriate use of PPE
6. Lack of data/information to monitor progress and needs)
7. Other (please specify)
8. None/there is no PPE shortage (skip next question)
19.b What are the three main 1. Financial planning support
technical assistance or support 2. Health worker training on appropriate use of PPE
interventions needed to address 3. Operational guidance and protocols for supply chain management
these bottlenecks? 4. Surge procurement of PPE
5. Guidance on developing national policies, strategies, or plans for scale
up of PPE
6. Rapid tools or guidance to assess and monitor gaps and health system
absorption capacities
7. Other (please specify)
209. What are the three main 1. Lack of funding (e.g. to procure or deliver vaccines)
a bottlenecks for potential scale up 2. Health workforce challenges (e.g. insufficient quantities distribution, or
of COVID-19 vaccination in your competencies to vaccinate populations)
country? 3. Shortages in vaccines and equipment at central or facility levels
(including vaccines, fridges and freezers)
4. Lack of distribution capacity (e.g. supply delays at central level)
5. Lack of clear strategy, guidance or protocols for vaccination roll out
6. Demand-side challenges (e.g. community acceptance for vaccination,
affordability)
7. Other (please specify)
8. None/scale up not needed (skip next question)
20.b What are the three main 1. Financial planning support
technical assistance or support 2. Health worker recruitment, retention and training
interventions needed to address 3. Operational guidance and protocols for supply chain management
these bottlenecks? 4. Procurement of vaccines
5. Guidance on developing national policies, strategies, or plans for scale
up of vaccination
9
6. Rapid tools or guidance to assess and monitor gaps and health system
absorption capacities
7. Risk communication and community engagement strategies
8. Other (please specify)
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for levels of disruption (question 7)
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Definitions for reasons for disruption (question 7)
• Intentional service delivery modifications: temporary scaling back or suspension/cancellation of services
• Decreased care-seeking: patients not presenting due to community fear/mistrust, financial difficulties during lockdown, or
other barriers to care.
• Unintended disruptions due to lack of health care resources: challenges related to health worker availability and capacities,
availability of essential health products, facility infrastructure and space capacities, etc.
Definition for health inequity analysis/es (question 12)
• Health inequity analyses may include:
o analyses using data disaggregated by sex, age, and at least two of the following inequality dimensions:
income/wealth, race, ethnicity, migratory status, disability, geographic location, and other SDH and characteristics
relevant in national contexts; or
o analyses on barriers to access to COVID19 health services related to situations of vulnerability and/or gender, ethnic,
or other forms of inequality and/or discrimination affecting their rights.
• The questions should be answered as “Yes” if either of the above criteria are met (either related to reports or research
produced by the Ministry of Health or another ministry).
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
10
In-depth modules on disruptions to tracer service
areas
11
Sexual, reproductive, maternal, newborn, child and adolescent health
To be completed by: Sexual, reproductive, maternal, newborn, child and adolescent health focal point(s)
This section will assess disruptions to services for sexual, reproductive, maternal, newborn, child and adolescent
health.
Respondent information
Who is the focal point who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
Service disruptions
1. 1.a Please indicate the level of disruption due to COVID-19 1.b How does this level of disruption compare to
during the previous 6 months (i.e. percentage of users not the level of disruption during the first quarter of
served as usual compared to before the pandemic) for the 2021 (January-March 2021)?
following sexual and reproductive health services.
Please respond for each service area.
Family planning and contraception [ ] More than 50% [ ] Still disrupted, worse than Jan-March 2021
[ ] 26-50% [ ] Still disrupted, better than Jan-March 2021
Safe abortion [ ] 5-25% [ ] Still disrupted, no change from Jan-March 2021
[ ] Less than 5% [ ] Back to pre-pandemic levels
Post-abortion care services (including 0%) [ ] Do not know
[ ] Do not know
Fertility care/infertility services [ ] Not applicable
Identification and care for intimate
partner violence
Response to sexual violence (post-
rape care)
2. During the previous 6 months, Communication and information
what mitigation strategies or 1. Informing the community, including adolescents, where, when and
service delivery modifications have how to access SRH services
been implemented to ensure 2. Providing information to public about accurate and up-to-date
continued delivery of sexual and educational materials on COVID-19 and SRH
reproductive health (SRH) services? 3. Informing and alerting all service providers about the heightened risk
of domestic violence
Please check all that apply. Access
4. Increasing availability of contraceptive methods and condoms that do
not require direct supervision of health workers through pharmacies
and other channels such as community-based delivery, and offering
12
alternative contraceptive options if a client’s regular method is not
available
5. Enhancing identification and services for gender-based violence
against women survivors across all age groups
Alternative or adaptive measures
6. Relaxing requirements for prescriptions of SRH commodities such as
oral or self-injectable contraception and abortion medications
7. Offering noninvasive medical methods for managing safe abortion
(including incomplete abortion)
8. Waiving restrictions to accessing SRH services (if these exist) such as
those based on age, marital status, or parental/spousal consent
9. Providing multi-month supplies of SRH commodities; with clear
information about the method and how to access referral care
10. Using hotlines and/or telemedicine to minimize facility visits and
provider-client contacts for various services including counseling,
information provision and support; organizing multiple service
provisions in single visit
11. Adjusting forecasting for SRH commodities and supplies
12. Reducing the cost of SRH services or providing SRH services free of
charge
13. Implement task shifting/sharing for essential SRH services (e.g.
stronger engagement of CHWs and/or pharmacists)
Other
14. Other (please specify):
15. Do not know
16. Not applicable
3. 3.a Please indicate the level of disruption due to COVID-19 during 3.b How does this level of disruption
the previous 6 months (i.e. percentage of users not served as usual compare to the level of disruption during
compared to before the pandemic) for the following maternal and the first quarter of 2021 (January-March
newborn health services. 2021)?
Please respond for each service area.
Antenatal care [ ] More than 50% [ ] Still disrupted, worse than Jan-March
[ ] 26-50% 2021
Facility-based births [ ] 5-25% [ ] Still disrupted, better than Jan-March
[ ] Less than 5% (including 2021
Postnatal care for women and 0%) [ ] Still disrupted, no change from Jan-
newborns [ ] Do not know March 2021
[ ] Not applicable [ ] Back to pre-pandemic levels
Neonatal intensive care unit [ ] Do not know
(NICU) services
4. During the previous 6 months, Communication and information
what mitigation strategies or 1. Informing the community where, when and how to access maternal
service delivery modifications have and newborn services
been implemented to ensure 2. Promoting childbirth in health facilities irrespective of COVID-19
continued delivery of maternal and 3. Informing families and caregivers on how to cope with stress and
newborn health (MNH) services? sustain a nurturing environment at home
13
4. Informing MNH CHWs on IPC measures, including PPE, and measures
Please check all that apply. for protection in absence of PPE
Access
5. Scheduling of antenatal care (ANC) visits in advance
6. Scheduling of postnatal care (PNC) visits in advance
7. Task shifting of non-clinical ANC interventions to community level
8. Tasking shifting of non-clinical PNC interventions to community level
9. Modifying (temporarily) MNH referral system to take into
consideration changes in service delivery
Alternative or adaptive measures
10. Offering multi-month prescriptions, micronutrient supplements, etc.
during ANC or PNC
11. Early discharge after normal delivery
12. Early discharge of stable high-risk (e.g. preterm, low birthweight)
newborns
13. Continuity of labour companion with appropriate screening for
COVID-19
14. Enhanced maternal mental health screening and counselling in
maternal health services
15. Using digital platforms for ANC or PNC counseling and screening to
minimize facility visits (e.g. breastfeeding support; self-care and family
care practices; informing for risk factors known to be increased in the
context of COVID-19 and for the occurrence of danger signs)
Other
16. Other (please specify):
17. Do not know
18. Not applicable
5. 5.a Please indicate the level of disruption due to COVID-19 during 5.b How does this level of disruption
the previous 6 months (i.e. percentage of users not served as usual compare to the level of disruption during
compared to before the pandemic) for the following child and the first quarter of 2021 (January-March
adolescent health services. 2021)?
Please respond for each service area.
Sick child services [ ] More than 50% [ ] Still disrupted, worse than Jan-March
[ ] 26-50% 2021
Well-child visits, including growth [ ] 5-25% [ ] Still disrupted, better than Jan-March
and developmental monitoring [ ] Less than 5% (including 2021
and counselling 0%) [ ] Still disrupted, no change from Jan-
[ ] Do not know March 2021
Adolescent and youth friendly [ ] Not applicable [ ] Back to pre-pandemic levels
services [ ] Do not know
6. During the previous 6 months, Communication and information
what mitigation strategies or 1. Informing the community on where, when and how to access sick and
service delivery modifications have well child care services
been implemented to ensure 2. Enhancing information to caregivers on child care (e.g. signs of illness;
continued delivery of child and when and where to seek care)
adolescent health services? 3. Providing information on how to manage stress and sustain nurturing
care in households during COVID-19
14
Please check all that apply. 4. Informing adolescents where and how to access health services
5. Informing adolescents where and how to get support and care in case
of violence
6. Informing health workers about the heightened risk to children and
adolescents of violence, including sexual violence
Access
7. Enhancing provision of mental health and psychosocial support to
caregivers of children and adolescents
8. Scheduling visits for child and/or adolescent services in advance
9. Enhance integrated outreach for delivery of vaccinations, growth
monitoring, preventive and sick child services
10. Offering multi-month prescriptions for children and adolescents with
conditions that require chronic care
Alternative or adaptive measures
11. Using digital platforms for counselling, screening and follow-up after
illness on matters related to child health
12. Shifting services for sick children and/or adolescents (e.g from hospital
to PHC or from PHC to community care)
13. Establishing hotlines and/or telemedicine for individual counselling of
adolescents
14. Engaging community groups and youth networks to extend the
provision of health information and services to adolescents
Other
15. Other (please specify):
16. Do not know
17. Not applicable
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for levels of disruption
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions)
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
15
Nutrition
To be completed by: Nutrition focal point(s)
This section will assess disruptions to nutrition services.
Respondent information
Who is the focal point who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
Service disruptions
1. 1.a Please indicate the level of disruption due to 1.b How does this level of disruption compare to the
COVID-19 during the previous 6 months (i.e. level of disruption during the first quarter of 2021
percentage of users not served as usual compared to (January-March 2021)?
before the pandemic) for the following service
areas.
Please respond for each service area.
Counselling on infant and [ ] More than 50% [ ] Still disrupted, worse than Jan-March 2021
young-child feeding (IYCF) [ ] 26-50% [ ] Still disrupted, better than Jan-March 2021
[ ] 5-25% [ ] Still disrupted, no change from Jan-March 2021
Screening for and/or [ ] Less than 5% [ ] Back to pre-pandemic levels
management of moderate (including 0%) [ ] Do not know
and severe wasting [ ] Do not know
[ ] Not applicable
Distribution of high dose
vitamin A supplementation
2. During the previous 6 months, Alternative or adaptive measures
what mitigation strategies or 1. Providing/prescribing nutrition drugs and supplies for multi-month (e.g.
service delivery modifications prescribe iron supplements to pregnant women for several months)
have been implemented to 2. Making use of alternative delivery channels for nutrition services (e.g.
ensure continued delivery of shift from facility-based delivery to community-based delivery of
nutrition services? counselling for exclusive breastfeeding, use of telephone/digital services
for IYCF counselling, highlighting that breastfeeding does not increase
Please check all that apply. the risk of transmission of COVID-19 to baby, provision of take-home
rations instead of school feeding)
3. Reducing the frequency of routine nutrition services, including screening
for severe wasting (e.g. conduct less frequent but periodic screening of
children for severe wasting)
4. Bundling nutrition services with other nutrition or health services (e.g.
joint campaigns for distribution of high dose vitamin A supplementation
and immunization)
16
5. Prioritizing key nutrition interventions (e.g. prioritize measurement of
birth weight, screening for severe wasting, treatment of severe wasting,
distribution of iron supplements for pregnant women etc. rather than
providing all nutrition services)
6. Task shifting for essential nutrition services (e.g. make CHWs responsible
for promotion of appropriate IYCF practices, screening of severe wasting
etc.)
7. Postponing of some nutrition services (e.g. counselling on nutrition and
healthy diets or any other services are postponed until the urgency of
COVID-19 response is over).
Other
8. Other (please specify):
9. Do not know
10. Not applicable
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for levels of disruption
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions)
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
17
Immunization
To be completed by: Immunization focal point(s)
This section will assess disruptions in supply and demand to immunization services.
Respondent information
Who is the focal point who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
Service disruptions
1. 1.a Please indicate the level of disruption due to COVID-19 and 1.b How does this level of disruption
associated epidemic prevention measures (other than COVID-19 compare to the level of disruption
vaccination) during the previous 6 months (i.e. percentage of users during the first quarter of 2021
not served as usual compared to before the pandemic) for the (January-March 2021)?
following routine immunization services (childhood, adolescent,
and adult non-COVID vaccination) services.
Please respond for each service area.
Routine facility-based [ ] More than 50% [ ] Still disrupted, worse than Jan-
immunization services [ ] 26-50% March 2021
[ ] 5-25% [ ] Still disrupted, better than Jan-
Routine outreach immunization [ ] Less than 5% (including 0%) March 2021
services [ ] Do not know [ ] Still disrupted, no change from
[ ] Not applicable Jan-March 2021
[ ] Back to pre-pandemic levels
[ ] Do not know
2. During the previous 6 months, Routine facility-based [ ] Yes
which of the following routine immunization services for: [ ] No
immunization services a. Infants/young children [ ] Do not know
(childhood, adolescent, and b. School-aged children and [ ] Not applicable
adult non-COVID vaccination) adolescents
have been disrupted due to c. Pregnant women
COVID-19 vaccination? d. Adults
Please respond for each service. Routine outreach immunization
services
3. Has the increased demand for a. Yes, for human resources
vaccination resources b. Yes, for needles or syringes
(vaccinators, cold chain, needles, c. Yes, for safety boxes to dispose used syringes and needles
syringes etc.) had a negative d. Yes, for cold chain equipment
impact on routine immunization e. Yes, for final disposal of injection wastage
services? f. No
18
g. Other (please specify):
Please check all that apply. h. Do not know
4. Please indicate the level of [ ] No disruptions: demand for immunization continues as before the
disruption in demand pandemic
(population seeking services) for [ ] Disruptions to demand for immunization, but less disruptions than
routine immunization in Jan-March 2021
(childhood, adolescent, and [ ] Disruptions to demand for immunization, and more disruptions than
adult non-COVID vaccination) as in Jan-March 2021
a result of COVID-19 and [ ] Disruptions to demand for immunization are similar to those seen
associated epidemic prevention in Jan-March 2021
measures (e.g. travel [ ] Do not know about disruptions to demand for routine immunization
restrictions, limitations in people
being in groups, etc.) during the
previous 6 months.
5. What kind of catch-up activities a. Periodic intensification of routine immunization (PIRI), such as
is the country implementing, or vaccination or health days or weeks
planning to implement before b. Enhanced routine immunization (providing additional routine
the end of 2021? This refers to immunization sessions)
vaccination activities aimed at c. Demand promotion campaigns (not targeted to only children who
vaccinating children who missed missed a dose)
vaccinations during the d. Targeted communication to families of children who have missed
pandemic. one or more doses
e. Mass vaccination campaigns (where children in the target age are
Please check all that apply. vaccinated regardless of previous vaccination status)
f. None
g. Other (please specify):
h. Do not know
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for levels of disruption
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions)
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
19
Human immunodeficiency virus and hepatitis
To be completed by: Human immunodeficiency virus and hepatitis focal point(s)
This section will assess disruptions to human immunodeficiency virus (HIV) and hepatitis services.
Respondent information
Who is the focal point who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
Service disruptions
1. 1.a Please indicate the level of disruption due to COVID-19 1.b How does this level of disruption
during the previous 6 months (i.e. percentage of users not compare to the level of disruption during
served as usual compared to before the pandemic) for the the first quarter of 2021 (January-March
following service areas. 2021?
Please respond for each service area.
Human immunodeficiency virus [ ] More than 50% [ ] Still disrupted, worse than Jan-March
(HIV) prevention services (e.g. [ ] 26-50% 2021
pre-exposure prophylaxis, [ ] 5-25% [ ] Still disrupted, better than Jan-March
provision of condoms and [ ] Less than 5% 2021
lubricants, voluntary medical male (including 0%) [ ] Still disrupted, no change from Jan-
circumcision, harm reduction [ ] Do not know March 2021
services) [ ] Not applicable [ ] Back to pre-pandemic levels
[ ] Do not know
Human immunodeficiency virus
(HIV) testing services
Continuation of established
antiretroviral (ARV) treatment
Initiation of new antiretroviral
(ARV) treatment
Hepatitis B and C diagnosis and
treatment
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for levels of disruption
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
20
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions)
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
21
Tuberculosis
To be completed by: Tuberculosis focal point(s)
This section will assess disruptions to tuberculosis (TB) services.
Respondent information
Who is the focal point who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
Service disruptions
1. 1.a Please indicate the level of disruption due to 1.b How does this level of disruption compare to
COVID-19 during the previous 6 months (i.e. the level of disruption during the first quarter of
percentage of users not served as usual compared 2021 (January-March 2021?
to before the pandemic) for the following service
areas.
Tuberculosis (TB) [ ] More than 50% [ ] Still disrupted, worse than Jan-March 2021
diagnosis and [ ] 26-50% [ ] Still disrupted, better than Jan-March 2021
treatment [ ] 5-25% [ ] Still disrupted, no change from Jan-March 2021
[ ] Less than 5% [ ] Back to pre-pandemic levels
(including 0%) [ ] Do not know
[ ] Do not know
[ ] Not applicable
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for levels of disruption
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions)
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
22
Malaria
To be completed by: Malaria focal point(s)
This section will assess disruptions to malaria services.
Respondent information
Who is the focal point who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
Service disruptions
1. 1.a Please indicate the level of disruption due to COVID-19 1.b How does this level of disruption
during the previous 6 months (i.e. percentage of users not compare to the level of disruption
served as usual compared to before the pandemic) for the during the first quarter of 2021 (January-
following service areas. March 2021?
Please respond for each service area.
Malaria diagnosis and treatment [ ] More than 50% [ ] Still disrupted, worse than Jan-March
[ ] 26-50% 2021
Malaria prevention campaigns [ ] 5-25% [ ] Still disrupted, better than Jan-March
a. Insecticide-treated-mosquito [ ] Less than 5% 2021
nets (ITN) (including 0%) [ ] Still disrupted, no change from Jan-
b. Indoor residual spraying (IRS) [ ] Do not know March 2021
c. Seasonal malaria [ ] Not applicable [ ] Back to pre-pandemic levels
chemoprevention (SMC) [ ] Do not know
Malaria surveillance
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for levels of disruption
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions)
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
23
Neglected tropical diseases
To be completed by: Neglected tropical diseases focal point(s)
This section will focus on neglected tropical diseases (NTDs). These include a diverse group of 20 diseases and
disease groups that are mostly communicable and primarily found in tropical and subtropical countries: Buruli
ulcer, Chagas disease, dengue and chikungunya, dracunculiasis (Guinea-worm disease), echinococcosis,
foodborne trematodiases, human African trypanosomiasis (sleeping sickness), leishmaniasis, leprosy (Hansen’s
disease), lymphatic filariasis, mycetoma, chromoblastomycosis and other deep mycoses, onchocerciasis (river
blindness), rabies, scabies and other ectoparasites, schistosomiasis, soiled-transmitted helminthiases, snakebite
envenoming, taeniasis/cysticercosis, trachoma, and yaws and other endemic treponematoses.
Respondent information
Who is the focal point who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
INFRASTRUCTURE AND ACTIVITIES
1. During the previous three months, have 1. YES – All staff supporting COVID-19 efforts full time
Ministry of Health (or equivalent 2. YES – All staff partially supporting COVID-19 efforts along
institutes) staff with responsibility for with routine NTD activities
NTDs been reassigned/deployed to help 3. YES – Some staff supporting COVID-19 efforts full time
with overall COVID-19 response? 4. YES – Some staff partially supporting COVID-19 efforts
along with routine NTD activities
5. NO
6. Do not know
2. During the previous three months, how 1. None or not yet
much of the government (or Ministry of 2. 1 - 25%
Health) funds initially allocated for NTDs 3. 26 -50%
have been reassigned to non-NTD 4. 51-75%
services due to COVID-19 response 5. 76 -100%
efforts? 6. Do not know
3. During the previous three months, which 1. Advocacy and resource mobilization for NTD programme
of the following planned Ministry of 2. Training and capacity‐building activities (in-person or
Health NTD activities have been virtual) related to NTDs
postponed because of COVID-19? (check 3. Surveys/population screening/surveillance for active case
all that apply) finding
If yes, please specify which NTD:
4. Integrated vector management
If yes, please specify which vector control activities (e.g.
mollusciciding, pond treatments, indoor residual/space
spraying, source reduction measures, environment
management)
24
5. Animal health/control of zoonotic NTDs
6. Monitoring, evaluation and research
7. Information reporting on NTDs
8. None
9. Do not know
SERVICE DISRUPTIONS
4. 4.a Please indicate the level of disruption due to COVID-19 during the 4.b How does this level of
previous 6 months (i.e. percentage of users not served as usual compared to disruption compare to the
before the pandemic) for the following service areas. level of disruption during
the first quarter of 2021
Please respond for each service area. (January-March 2021?
Diagnosis, treatment and care for NTDs [ ] More than 50% [ ] Still disrupted, worse
(facility-based) [ ] 26-50% than Jan-March 2021
[ ] 5-25% [ ] Still disrupted, better
Large scale preventive chemotherapy [ ] Less than 5% (including 0%) than Jan-March 2021
campaigns for NTDs (e.g. mass drug [ ] Do not know [ ] Still disrupted, no
administrations, and/or school-based [ ] Not applicable change from Jan-March
treatments) 2021
[ ] Back to pre-pandemic
Community awareness and health levels
education campaigns for NTDs (e.g. [ ] Do not know
WASH promotion, disease prevention,
vector control, eradication)
Support for self-care, rehabilitation and
psychosocial services for patients with
chronic NTDs
Prescriptions for NTD medicines
Surgical procedures for NTDs
5. During the previous three months, what
1. Mortality related to NTDs [ ] Increased
has been the impact of COVID-19 on the
2. Funding for related NTD [ ] Reduced
following? activities [ ] No change or effect
3. Visibility of population at [ ] Do not know
Please respond for each outcome. risks for NTDs [ ] Not applicable
4. Prioritization of NTD
activities
5. Expiration of NTD medicines
and diagnostics
6. Stock out of NTD medicines
and diagnostics
7. Other impact on NTDs
activities and/or outcomes
(please specify)
WHO GUIDANCE: UPTAKE, INFORMATION SHARING AND UNMET NEEDS
25
6. Are there any technical guidance or tools Please use the text box to give your suggestions
that you would suggest WHO to develop
related to NTDs during COVID-19
outbreak?
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for levels of disruption (question 4)
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions)
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
Please visit https://www.who.int/neglected_diseases/diseases/summary/en/ for more information on NTDs.
26
Mental, neurological, and substance use disorders
To be completed by: Mental health, neurology and substance abuse focal point(s)
This section will assess disruptions in services for mental, neurological and substance use disorders. Focal points
may also reach out to national neurological associations/expert groups to gather information, if not readily
available in Ministry of Health.
Respondent information
Who is the focal point who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
Policies and plans
1.a Is mental health and psychosocial a. Yes
support response part of national b. No
COVID-19 response plan? c. Do not know
1.b If yes to 1.a, during the previous 6 a. Yes, 100 % funded
months, has additional funding been b. Yes, but less than 33% funded
allocated for mental health and c. Yes, but 33%-66% funded
psychosocial support in the d. Yes, but 67%-99% funded
government budget for the COVID-19 e. No
response plan? f. Do not know
1.c If yes to 1.a, during the previous six a. Orient responders to mental health and psychosocial
months, which of the following aspects of COVID-19
activities have been implemented as b. Ensure inter-sectoral referral pathways are established and
part of the current mental health and contextualized to the situation of limited physical distancing
psychosocial support (MHPSS) c. Distribute timely and accessible information on general and
response plan for COVID-19? MHPSS services, coping strategies and updates
(Please check all activities that apply) d. Provide MHPSS to people in COVID treatment centers,
isolation and quarantine
See further examples for each activity in e. Protect the mental health and well-being of all responders
the complementary glossary - section A. ensuring that they can access mental health and
psychosocial care.
f. Provide care and address the basic needs and mental health
care needs of people with existing MNS conditions induced
or exacerbated by COVID-19
g. Address the specific mental health and neurological needs
of older adults, people with disabilities and other
vulnerable persons
h. Targeted Risk communication strategies/ campaigns to
address social stigma
27
i. Establish opportunities for the bereaved to mourn even from
a distance. Integrate response activities into existing
services
j. Ensure that risk of infection for people with mental
neurological and substance use disorders in mental health
hospitals and long-term care facilities are minimized
k. Establish services for the identification, management and
monitoring of people with post-COVID-condition with
mental and neurological sequelae
l. Do not know
2.a Do you currently have a functioning a. Yes
multisectoral mental health and b. No
psychosocial coordination platform c. Do not know
for COVID-19 response?
2.b If yes to 2.a, which of the following a. Ministry of Health
Ministries and bodies are part of the b. Ministry of Social/Family Affairs
coordination platform? c. Ministry of Education
d. Ministry of Labour
Please check all that apply. e. Ministry of Finance
f. Ministry of Foreign Affairs
g. United Nations Agencies
h. Governmental entity responsible for substance use
i. Non-governmental Organizations
j. Service users’ representatives
k. National professional associations/societies
l. National disaster management authority
m. Do not know
3. Does your country’s COVID-19 a. Yes and 100 % funded
response and/or recovery plan b. Yes but only less than 33% funded
include provisions for services and c. Yes but between 33% and 66% funded
supports for people with post-COVID d. Yes but between 67% and 99% funded
condition, especially mental and e. No
neurological sequelae of post-COVID f. Do not know
condition?
4. During the previous 6 months, how Level Status
have government policies/directives Mental health services at [ ] Services are open
designated access to essential stand-alone psychiatric [ ] Services are partially open
services for mental, neurological and hospitals [ ] Services are closed
substance use (MNS) disorders at [ ] Do not know
primary, secondary and tertiary care Specialized MNS services at [ ] Not Applicable
levels? general hospitals
Please answer for different categories of Specialized neurology
services for mental, neurological and services at health facilities
substance use disorders (see
complementary glossary – section B). Specialized services for
substance use disorders at
health facilities
28
Community-based services
for MNS disorders including
in primary care facilities
Service disruptions
5. 5.a Please indicate the level of disruption due to COVID-19 during the 5.b How does this level of
previous 6 months (i.e. percentage of users not served as usual disruption compare to the level
compared to before the pandemic) for the following service areas. of disruption during the first
quarter of 2021 (January-March
Please respond for each service area. 2021?
Management of emergency MNS [ ] More than 50% [ ] Still disrupted, worse than
manifestations (including suicide [ ] 26-50% Jan-March 2021
attempt, status epilepticus, delirium, [ ] 5-25% [ ] Still disrupted, better than
drug overdose, severe substance [ ] Less than 5% (including 0%) Jan-March 2021
withdrawal syndromes) [ ] Do not know [ ] Still disrupted, no change
[ ] Not applicable from Jan-March 2021
Psychotherapy/counseling/psychoso [ ] Back to pre-pandemic
cial interventions for MNS disorders levels
[ ] Do not know
Availability of psychotropic
medicines for management of MNS
disorders
Services for children and adolescents
with mental health conditions or
disabilities, including developmental
disabilities
Services for older adults with mental
health conditions or disabilities,
including dementia
Neuroimaging and neurophysiology
School mental health programme
Inclusive schooling for children with
special needs
Suicide prevention programme
Substance use prevention and
management programs
Alcohol prevention and
management programs
29
Critical harm reduction services (e.g.,
needle exchange programs, outreach
services)
Surveillance
6. Is your country collecting or collating a. Yes, for people with acute COVID-19 infection
data on mental, neurological and b.Yes, for people with post-COVID condition
substance use disorders or c. Yes, for people with acute COVID-19 infections and post-
manifestations in people with COVID- COVID condition
19 and/or post-COVID-19 condition? d.No
e. Do not know
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for status of service as defined by national level policies/directives (question 4)
• Services open: Regular access to services
• Services partially open: e.g for emergencies only or at limited capacity
• Services closed: No access to services
• Do not know: Information not available / to be found
• N/A: Not applicable as services non-existent
Definitions for levels of disruption (question 5)
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions)
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
30
Care for older people
To be completed by: Care for older people focal point(s)
This section will assess disruptions to services and care for older people.
Respondent information
Who is the focal point who provided the responses?
Name: _______________________________________
Position: _______________________________________
Organization: _______________________________________
Country: _______________________________________
Email Address: _______________________________________
# Questions Response options
Service disruptions
1. 1.a Please indicate the level of disruption due to 1.b How does this level of disruption compare to the
COVID-19 during the previous 6 months (i.e. level of disruption during the first quarter of 2021
percentage of users not served as usual compared to (January-March 2021)?
before the pandemic) for the following service
areas.
Please respond for each service area.
Health and social care services [ ] More than 50% [ ] Still disrupted, worse than Jan-March 2021
in long-term care facilities [ ] 26-50% [ ] Still disrupted, better than Jan-March 2021
(e.g. nursing homes) [ ] 5-25% [ ] Still disrupted, no change from Jan-March 2021
[ ] Less than 5% [ ] Back to pre-pandemic levels
Health and social care services (including 0%) [ ] Do not know
in the community (e.g. day [ ] Do not know
care centres and home visits) [ ] Not applicable
Screening and assessment of
physical and mental capacities
for older people (e.g. mobility,
cognition, mood, nutrition,
vision and hearing)
Provision of integrated health
and social care services for
older people (e.g.
management of functional
decline, noncommunicable
diseases management,
vaccination)
2. During the previous 6 months, Communication and information
what mitigation strategies or 1. Inform older people, their households and caregivers with targeted
service delivery modifications messages, regarding where, when and how to access health and long-term
have been implemented to care services (e.g. day care centres, home visits)
31
ensure continued delivery of 2. Inform older people, their households and caregivers on IPC measures
care and services for older 3. Inform older people, their households and caregivers on the importance of
people? promoting physical and mental health (self-care and self-management),
and monitoring for impact of social isolation
Please check all that apply. 4. Inform older people, their households and their caregivers, on where and
how to report and get help in the case of elder abuse
5. Inform health workers about the heightened risk of elder abuse
6. Ensure accessible information and different communication strategies for
older people with impairments (e.g. low vision or blindness, hearing loss,
cognitive decline or dementia)
7. Establish hotlines for older people and care givers to provide targeted
information for older people
8. Provide accurate accessible information of COVID-19 vaccines and access to
COVID-19 vaccines according to national vaccine policies
Access
9. Use telemedicine and/or home outreach proactively to minimize health
facility visits and schedule visits in advance for older people with underlying
conditions, who live alone, and those who are care dependent
10. Offer multi-month prescriptions for older adults who have underlying
health conditions
11. Establish mechanisms for medication delivery for older adults who have
underlying health conditions
12. Facilitate access to rehabilitation services (home exercise programmes,
assistive products, tele-rehabilitation).
Alternative or adaptive measures
13. Engaging community groups and networks to extend the provision of
health information and services to older people
14. Introduce (if doesn’t exist) psychosocial support for older people, for those
socially isolated and with grief and loss
15. For older people who are care dependent, develop with the older person
an alternative plan in case the primary caregiver is unavailable, and identify
an alternative caregiver or alternative facility, or both
16. Provide education and training for caregivers at home and long-term care
facilities on IPC measures and how to continue providing care safely
17. Establish and enhance the mechanism for relieving the burden on
caregivers, including providing psychological support using digital platforms
and respite care
Other
18. Other (please specify):
19. Do not know
20. Not applicable
Note:
Unless otherwise specified, questions refer to the 6 month period preceding survey completion. In the case of survey completion during
November 2021, this refers to the situation during May-October 2021.
Definitions for levels of disruption
• More than 50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• 26-50% of users not served as usual (i.e. as prior to COVID-19 pandemic)
32
• 5-25% of users not served as usual (i.e. as prior to COVID-19 pandemic)
• Less than 5% of users not served as usual (i.e. as prior to COVID-19 pandemic), including 0% / no disruptions)
• Do not know: Information is not /not yet available
• Not applicable: Service/intervention is not usually delivered in country
Thank you for taking time to give your input for this survey. If you have any queries or questions regarding this
survey, please contact
[email protected]
33
Annex: Data sharing agreement
Please note that all data collected by WHO, excluding emergencies and clinical trials, from member States
requires the below statement in all data collection forms.
For more information on the data policy go to: http://intranet.who.int/homes/spi/datasharing/
or outside of WHO: https://www.who.int/about/policies/publishing/data-policy
Statement of policy on data sharing
Data are the basis for all sound public health actions and the benefits of data sharing are widely recognized,
including scientific and public health benefits. Whenever possible, WHO wishes to promote the sharing of health
data, including but not restricted to surveillance and epidemiological data.
In this connection, and without prejudice to information sharing and publication pursuant to legally binding
instruments, by providing data to WHO, the [Ministry of Health] [other responsible governmental entity] of
[Country]:
Confirms that all data to be supplied to WHO (including but not limited to the types listed in Annex 3)
hereunder have been collected in accordance with applicable national laws, including data protection laws
aimed at protecting the confidentiality of identifiable persons;
Agrees that WHO shall be entitled, subject always to measures to ensure the ethical and secure use of the data,
and subject always to an appropriate acknowledgement of [Country]:
- to publish the data, stripped of any personal identifiers (such data without personal identifiers being
hereinafter referred to as “the Data”) and make the Data available to any interested party on request
(to the extent they have not, or not yet, been published by WHO) on terms that allow non-commercial,
not-for-profit use of the Data for public health purposes (provided always that publication of the Data
shall remain under the control of WHO);
- to use, compile, aggregate, evaluate and analyze the Data and publish and disseminate the results
thereof in conjunction with WHO’s work and in accordance with the Organization’s policies and
practices.
Except where data sharing and publication is required under legally binding instruments (IHR, WHO
Nomenclature Regulations 1967, etc.), the [Ministry of Health][other responsible governmental entity] of
[Country] may in respect of certain data opt out of (any part of) the above, by notifying WHO thereof in writing
at the following address, provided that any such notification shall clearly identify the data in question and clearly
indicate the scope of the opt-out (in reference to the above), and provided that specific reasons shall be given
for the opt out.
World Health Organization
WHO HQ/IHS/HSA
1211 Geneva 27
Switzerland
[email protected]
[ ] I verify that I have read and understood the data sharing agreement
34
WORLD HEALTH ORGANIZATION
ORGANISATION MONDIALE DE LA SANTÉ
WELTGESUNDHEITSORGANISATION Date: 4 November 2021
ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONAL OFFICE FOR EUROPE Ms Kaija Kasekamp
BUREAU RÉGIONAL DE L’EUROPE
REGIONALBÜRO FÜR EUROPA
Adviser
ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО Health System Development Department
Head office:
Ministry of Social Affairs
UN City, Marmorvej 51, Suur-Ameerika 1
DK-2100 Copenhagen Ø, Denmark Tallinn 10129
Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01
Email:
[email protected] Estonia
Website: http://www.euro.who.int
Our reference: Pulse Your reference:
Notre référence: 3rd round Votre référence:
Unser Zeichen: Ihr Zeichen:
См. наш номер: На Ваш номер:
Dear Ms Kasekamp,
Third Round of the National Pulse Survey
on Continuity of Essential Health Services During the COVID-19 Pandemic
We are contacting you to request your leadership and support to facilitate country completion of the
third round of the National pulse survey on continuity of essential health services during the COVID-
19 pandemic.
As you know, the aim of the survey is to rapidly assess the impact of COVID-19 on the continuity of
essential health services and track how countries are responding to mitigate challenges and recover
services. It is also a valuable resource to inform action plans, resource allocation, and policy dialogues
at country and global levels, and is a critical input for monitoring WHO’s COVID-19 Strategic
preparedness and response plan.
We will be very grateful for your usual collaboration in disseminating the survey to the Ministry of
Health in your country and facilitating its completion by 23 November 2021. The survey and
background information on suggested process for completion is enclosed and the unique country link
is included below.
Access survey:
https://extranet.who.int/dataformv3/index.php/plugins/direct?plugin=PulseProjects&project=pulse&to
ken=66566434
Token: 66566434
It is recommended that a focal point in the WHO Country Office and/or Ministry of Health be
designated to coordinate the survey responses with key informants/national focal points. As feasible,
please designate a WHO Country Office focal point to collaborate with the Ministry of Health in
your country on survey completion. We will be grateful if you can keep
[email protected]
in copy to provide technical backstopping and answer any questions.
UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email:
[email protected]
DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int
Denmark
Please contact Florian Tille (
[email protected]) or
[email protected] with any further questions,
and we thank you for your continued collaboration.
Yours sincerely,
Dr Natasha Azzopardi Muscat
Director
Division of Country Health Policies and Systems
Enclosure: 1. Final pulse survey
Copy for information:
Ms Elen Ohov, Adviser, European Union Affairs and International Co-operation Department, Ministry of
Social Affairs, Suur-Ameerika 1, Tallinn 10122, Estonia
Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81,
Tallinn 10617, Estonia
–2–